南京招聘

Global Regulatory Affairs Internship
Bayer HealthCare (BHC) makes an important contribution to human and animal health with its innovative products and by researching new therapeutic approaches promoting science for a better life throughout everything that we do. Our Specialty Pharmaceutical business ranks among the top 10 specialty pharmaceutical companies worldwide. Our global research and development is focused in five distinct areas: Diagnostic Imaging, Hematology/Cardiology, Oncology, Specialized Therapeutics, and Women's Healthcare. As a specialty pharmaceuticals company, we focus our efforts in areas of high unmet medical need and where we can have the most impact. Our Medical Care division consists of Diabetes Care and Radiology and Interventional. The Diabetes Care division is one of the largest blood glucose monitoring businesses in the world, supporting customers in 100 countries. Radiology and Interventional is the world's leading supplier of contrast agents and injection systems for diagnostic and therapeutic medical procedures. The business also supplies mechanical systems for removing thrombi from blood vessels. Our Consumer Care business is a top competitor in many important product categories including analgesics, cough and cold, and nutritionals. More than 3,000 employees support 14 manufacturing sites in 11 countries dedicated to ensuring the delivery of a secure, high-quality, cost-effective supply of our products around the world. Our Animal Health business in North America is dedicated to making the world a better place for our veterinary customers, their clients, and the animals we all hold dear.

Job description
We are looking for dynamic individuals to join the Bayer team who are interested in pursuing a career in Global Regulatory Affairs. Recent graduates are welcome to apply. Candidates must be available for a 3-month assignment at Bayer's New Jersey site.
As an Intern within the Global Regulatory Affairs department, the incumbent will gain valuable work experience in the healthcare industry while working on various project activities to learn about the challenges within the regulatory environment. Along with on the job training, candidates will be assigned a mentor and expected to deliver a project at the end of the internship.
Global Regulatory Affairs works with Health Authorities in over 100 countries, giving you the opportunity to work in a truly global workplace. The current regulatory environment is changing rapidly and we are looking for future leaders who are interested in working with Health Authorities such as the European Medicines Agency (EMA) in the EU, the Food and Drug Administration (FDA) in the US or the State Food and Drug Administration (SFDA) in China.

Your qualifications
Successful candidates must be a high performer with a global perspective, interested in the interactions between science and policy, wants to work with dynamic people and contribute to a changing environment.
Advanced degree (Masters/PhD/MD) in policy/administration, public health, health sciences, pharmacy, medicine, or related field.
Good oral and written communication skills.
Ability to display poise and confidence and to project professionalism in interacting with internal and external stakeholders.
Students are eligible to apply if they meet the criteria required of all interns including being legally entitled to work and earn money in the US. It is the student's responsibility to obtain the appropriate visa, if applicable. As required by current immigration law, an offer of employment is contingent upon the student's ability to provide the appropriate documentation showing proof of eligibility to work in the US.


Your application
If you meet the requirements of this unique opportunity, we encourage you to explore how you can make a difference by applying now.

Deadline to apply: December 31, 2012.
CV receiving mail: Monica.wu@bayer.com

To all recruitment agencies: Bayer does not accept unsolicited third party resumes.

拜耳医药保健是拜耳集团的子集团，是世界十大医药企业之一，也是医药保健及医疗产品行业世界领先的创新企业之一，全球拥有员工53100人，总部位于德国的勒沃库森。拜耳医药保健致力于研究开发、生产和销售用于预防、诊断和治疗疾病的原研产品。2008年，拜耳医药保健全球销售额达154.07亿欧元，其中研发经费为17.42亿欧元，占拜耳集团总研发投入的66%。

拜耳医药保健和中国的渊源可以追溯到20世纪初期。早在1936年，拜耳就在中国成立第一个生产公司－拜耳医药公司，生产一系列产品。目前，拜耳医药保健有限公司在中国拥有员工约4000人，总部位于北京。在北京、广州、成都、江苏设有工厂，致力于拜耳先灵医药、保健消费品、糖尿病保健及动物保健四大业务。其中，拜耳先灵医药是拜耳医药保健有限公司下属最大业务部门，是拜耳医药保健的处方药部和先灵（广州）药业有限公司合并而成，业务遍及70多个城市，产品线覆盖普药业务、女性健康、特殊治疗以及影像诊断四个领域。2008年7月，拜耳医药保健的保健消费品部收购了东盛盖天力西药非处方药业务。
        
2008年，拜耳医药保健完成了投资达2.2亿余元人民币的北京生产厂的扩建。 北京工厂新建的生产线将采用目前中国乃至亚洲地区最为先进的设备，产能是以前的4倍。除了硬件系统投资，拜耳医药保健北京工厂还引入先进的软件管理系统，包括全自动称重系统、物流管理系统等将使得药品的品质更上一层楼。

拜耳医药保健有限公司在中国的发展蒸蒸日上。

在业务发展的同时，拜耳医药保健始终不忘社会责任，积极与社会各方面进行深入合作。2008年11月，与中国就业促进会合作开展了“农业富余劳动力健康安全转移就业培训项目”，计划在3年内对3万名农业富余劳动力免费提供健康安全转移就业培训。尽管目前处在全球经济困难期，我们仍将继续关注那些需要帮助的社会弱势人群。

为促进并提高中西部地区县级医院的整体医疗服务技术水平，2008年拜耳医药保健和卫生部合作的“走进西部”万名县级医院医师培训项目成功开展。目前已在甘肃、青海、宁夏、云南四省进行了６期培训工作，已有３６３人参加了培训。２００９年“走进西部”项目还将延伸到江西、广西、陕西、贵州、新疆等五个省份，共计划培训１１２２名医生。

2009年初，拜耳医药保健新的研发中心将在北京落户，成为其全球架构中的第四大研发中心。这一举措不仅表明了我们在中国长期发展的决心和信心，并为拜耳医药保健成为亚洲制药领域的领导者提供坚实基础。